Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sodium polystyrene sulfonate 99.934% (binding capacity 3.1meq/g);  ;   - powder for oral solution - 3.1 meq/g - active: sodium polystyrene sulfonate 99.934% (binding capacity 3.1meq/g)     excipient: saccharin sodium vanillin - treatament of hyperkalaemia.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - haloperidol 0.5mg - tablet - 0.5 mg - active: haloperidol 0.5mg excipient: acacia acid green 50 calcium hydrogen phosphate dihydrate lactose monohydrate magnesium stearate maize starch quinoline yellow - the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - haloperidol 1.5mg - tablet - 1.5 mg - active: haloperidol 1.5mg excipient: acacia calcium hydrogen phosphate dihydrate lactose monohydrate magnesium stearate maize starch - the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - haloperidol 5mg - tablet - 5 mg - active: haloperidol 5mg excipient: acacia calcium hydrogen phosphate dihydrate lactose monohydrate magnesium stearate maize starch ponceau 4r - the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - haloperidol 2 mg/ml; haloperidol 2 mg/ml - oral solution - 2 mg/ml - active: haloperidol 2 mg/ml haloperidol 2 mg/ml excipient: lactic acid methyl hydroxybenzoate propyl hydroxybenzoate purified water - the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - dexamethasone sodium metasulfobenzoate 0.076%{relative} equivalent to 0.05% w/v dexamethasone; framycetin sulfate 0.67%{relative} equivalent to 0.5% framycetin;  ; gramicidin 0.005%{relative} - ear/eye drops - active: dexamethasone sodium metasulfobenzoate 0.076%{relative} equivalent to 0.05% w/v dexamethasone framycetin sulfate 0.67%{relative} equivalent to 0.5% framycetin   gramicidin 0.005%{relative} excipient: citric acid monohydrate hydrochloric acid lithium chloride as lithium chloride solution 50%w/v methylated spirits phenethyl alcohol polysorbate 80 purified water sodium citrate dihydrate sodium hydroxide - in the eye: for the short term treatment of steroid responsive conditions of the eye when prophylactic antibiotic treatment is also required, after excluding the presence of fungal or viral disease. in the ear: otitis externa.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - framycetin sulfate 0.55%{relative} (at a framycetin potency of 670µg /mg);   - ear/eye drops - 0.55 % - active: framycetin sulfate 0.55%{relative} (at a framycetin potency of 670µg /mg)   excipient: benzalkonium chloride citric acid monohydrate sodium chloride sodium citrate dihydrate water for injection

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - eculizumab 300mg;  ;  ;   - solution for infusion - 300mg/30ml - active: eculizumab 300mg       excipient: dibasic sodium phosphate heptahydrate monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection - soliris® is indicated for the treatment of patients with paroxysmal nocturnal haemoglobinuria (pnh)to reduce haemolysis.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - prochlorperazine mesilate 12.5 mg/ml;   - solution for injection - 12.5 mg/ml - active: prochlorperazine mesilate 12.5 mg/ml   excipient: olamine sodium chloride sodium metabisulfite sodium sulfite water for injection - prochlorperazine is used for nausea and vomiting from whatever cause. it may also be used for migraine, schizophrenia (particularly in the chronic stage) and acute mania.

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - antithymocyte immunoglobulin 25mg (rabbit) - powder for infusion - 25 mg - active: antithymocyte immunoglobulin 25mg (rabbit) excipient: glycine mannitol sodium chloride - thymoglobuline® (rabbit anti - human thymocyte immunoglobulin) is indicated for the prophylaxis of graft rejection in renal transplantation; treatment of steroid - resistant or moderate to severe renal transplant rejection and in the prophylaxis of graft rejection in heart transplantation.